Participant guide
How studies are reviewed and monitored
No study can enroll anyone until an independent committee has reviewed it, and the review continues while the study runs.
Updated
Independent review
An Institutional Review Board, or IRB, is a committee that is independent of the researchers. It reviews the study plan and the consent document before a study starts, and it keeps reviewing while the study is under way. Its job is to protect the rights and welfare of the people taking part.
Who runs CNS medication studies
As of November 17, 2026, 410 CNS medication studies are recruiting participants in the United States, according to ClinicalTrials.gov. By sponsor: university, hospital or other (202), industry (181), government (27). The sponsor is the organization responsible for a study.
Federal rules
Research in the United States is governed by federal regulations that set out how participants must be informed and protected. Studies of medications and devices are also overseen by the U.S. Food and Drug Administration.
Monitoring during the study
The study team follows your health at scheduled visits and records any problems you report. If a serious concern appears, a study can be changed, paused, or stopped.
Oversight lowers risk. It does not remove it. Every study has risks, and the consent document describes the ones that are known.
Talk with a study coordinator
Call (888) 927-5768 or send a short form and a coordinator will explain which studies may fit and what the next step looks like. Asking questions does not commit you to anything.
Sources and further reading
- Institutional Review Boards (IRBs) and Protection of Human Subjects in Clinical Trials — U.S. Food and Drug Administration
- Regulations to Protect Research Participants — HHS Office for Human Research Protections
- 45 CFR 46 — Protection of Human Subjects — U.S. Department of Health and Human Services